-
Something wrong with this record ?
Effect of O-methyl-β-cyclodextrin-modified magnetic nanoparticles on the uptake and extracellular level of l-glutamate in brain nerve terminals
D. Horák, M. Beneš, Z. Procházková, M. Trchová, A. Borysov, A. Pastukhov, K. Paliienko, T. Borisova,
Language English Country Netherlands
Document type Journal Article
- MeSH
- beta-Cyclodextrins chemistry pharmacology MeSH
- Biological Transport drug effects MeSH
- Cell Membrane drug effects metabolism MeSH
- Cholesterol isolation & purification metabolism pharmacology MeSH
- Kinetics MeSH
- Rats MeSH
- Glutamic Acid metabolism MeSH
- Magnetite Nanoparticles chemistry MeSH
- Membrane Potentials drug effects MeSH
- Brain drug effects metabolism MeSH
- Rats, Wistar MeSH
- Presynaptic Terminals drug effects metabolism MeSH
- Carbon Radioisotopes MeSH
- Silanes chemistry MeSH
- Synaptosomes drug effects metabolism MeSH
- Ferric Compounds chemistry MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
Changes in cholesterol concentration in the plasma membrane of presynaptic nerve terminals nonspecifically modulate glutamate transport and homeostasis in the central nervous system. Reduction of the cholesterol content in isolated rat brain nerve terminals (synaptosomes) using cholesterol-depleting agents decreases the glutamate uptake and increases the extracellular level of glutamate in nerve terminals. Extraction of cholesterol from the plasma membrane and its further removal from the synaptosomes by external magnetic field can be achieved by means of magnetic nanoparticles with immobilized cholesterol-depleting agent such as O-methyl-β-cyclodextrin (MCD). A simple approach is developed for preparation of maghemite (γ-Fe2O3) nanoparticles containing chemically bonded MCD. The method is based on preparation of a silanization agent containing MCD. It is synthesized by the reaction of triethoxy(3-isocyanatopropyl)silane with MCD. Base-catalyzed silanization of superparamagnetic γ-Fe2O3 provides a relatively stable colloid product containing 48μmol of MCDg(-1). MCD-modified γ-Fe2O3 nanoparticles decrease the initial rate of the uptake and accumulation of l-[(14)C]glutamate and increase the extracellular l-[(14)C]glutamate level in the preparation of nerve terminals. The effect of MCD-immobilized nanoparticles is the same as that of MCD solution; moreover, magnetic manipulation of the nanoparticles enables removal of bonded cholesterol.
Leontovich Str Kiev 01601 Ukraine
Palladin Institute of Biochemistry National Academy of Sciences of Ukraine
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17013489
- 003
- CZ-PrNML
- 005
- 20170502100047.0
- 007
- ta
- 008
- 170413s2017 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.colsurfb.2016.10.007 $2 doi
- 035 __
- $a (PubMed)27721167
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Horák, Daniel $u Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovsky Sq. 2, 162 06 Prague 6, Czech Republic. Electronic address: horak@imc.cas.cz.
- 245 10
- $a Effect of O-methyl-β-cyclodextrin-modified magnetic nanoparticles on the uptake and extracellular level of l-glutamate in brain nerve terminals / $c D. Horák, M. Beneš, Z. Procházková, M. Trchová, A. Borysov, A. Pastukhov, K. Paliienko, T. Borisova,
- 520 9_
- $a Changes in cholesterol concentration in the plasma membrane of presynaptic nerve terminals nonspecifically modulate glutamate transport and homeostasis in the central nervous system. Reduction of the cholesterol content in isolated rat brain nerve terminals (synaptosomes) using cholesterol-depleting agents decreases the glutamate uptake and increases the extracellular level of glutamate in nerve terminals. Extraction of cholesterol from the plasma membrane and its further removal from the synaptosomes by external magnetic field can be achieved by means of magnetic nanoparticles with immobilized cholesterol-depleting agent such as O-methyl-β-cyclodextrin (MCD). A simple approach is developed for preparation of maghemite (γ-Fe2O3) nanoparticles containing chemically bonded MCD. The method is based on preparation of a silanization agent containing MCD. It is synthesized by the reaction of triethoxy(3-isocyanatopropyl)silane with MCD. Base-catalyzed silanization of superparamagnetic γ-Fe2O3 provides a relatively stable colloid product containing 48μmol of MCDg(-1). MCD-modified γ-Fe2O3 nanoparticles decrease the initial rate of the uptake and accumulation of l-[(14)C]glutamate and increase the extracellular l-[(14)C]glutamate level in the preparation of nerve terminals. The effect of MCD-immobilized nanoparticles is the same as that of MCD solution; moreover, magnetic manipulation of the nanoparticles enables removal of bonded cholesterol.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a biologický transport $x účinky léků $7 D001692
- 650 _2
- $a mozek $x účinky léků $x metabolismus $7 D001921
- 650 _2
- $a radioizotopy uhlíku $7 D002250
- 650 _2
- $a buněčná membrána $x účinky léků $x metabolismus $7 D002462
- 650 _2
- $a cholesterol $x izolace a purifikace $x metabolismus $x farmakologie $7 D002784
- 650 _2
- $a železité sloučeniny $x chemie $7 D005290
- 650 _2
- $a kyselina glutamová $x metabolismus $7 D018698
- 650 _2
- $a kinetika $7 D007700
- 650 _2
- $a magnetické nanočástice $x chemie $7 D058185
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a membránové potenciály $x účinky léků $7 D008564
- 650 _2
- $a presynaptická zakončení $x účinky léků $x metabolismus $7 D017729
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a silany $x chemie $7 D012821
- 650 _2
- $a synaptozomy $x účinky léků $x metabolismus $7 D013574
- 650 _2
- $a beta-cyklodextriny $x chemie $x farmakologie $7 D047392
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Beneš, Milan $u Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovsky Sq. 2, 162 06 Prague 6, Czech Republic.
- 700 1_
- $a Procházková, Zuzana $u Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovsky Sq. 2, 162 06 Prague 6, Czech Republic.
- 700 1_
- $a Trchová, Miroslava $u Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic, Heyrovsky Sq. 2, 162 06 Prague 6, Czech Republic.
- 700 1_
- $a Borysov, Arsenii $u Palladin Institute of Biochemistry, National Academy of Sciences of Ukraine; 9 Leontovich Str., Kiev, 01601, Ukraine.
- 700 1_
- $a Pastukhov, Artem $u Palladin Institute of Biochemistry, National Academy of Sciences of Ukraine; 9 Leontovich Str., Kiev, 01601, Ukraine.
- 700 1_
- $a Paliienko, Konstantin $u Palladin Institute of Biochemistry, National Academy of Sciences of Ukraine; 9 Leontovich Str., Kiev, 01601, Ukraine.
- 700 1_
- $a Borisova, Tatiana $u Palladin Institute of Biochemistry, National Academy of Sciences of Ukraine; 9 Leontovich Str., Kiev, 01601, Ukraine.
- 773 0_
- $w MED00180202 $t Colloids and surfaces. B, Biointerfaces $x 1873-4367 $g Roč. 149, č. - (2017), s. 64-71
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27721167 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170413 $b ABA008
- 991 __
- $a 20170502100413 $b ABA008
- 999 __
- $a ok $b bmc $g 1199954 $s 974267
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 149 $c - $d 64-71 $e 20161004 $i 1873-4367 $m Colloids and surfaces. B, Biointerfaces $n Colloids surf., B Biointerfaces $x MED00180202
- LZP __
- $a Pubmed-20170413